HOUSEY PHARMA RESEARCH
Housey Pharma focuses upon the creation and discovery of new drugs to treat rapidly and uniformly fatal human diseases as well as certain chronic diseases for which current therapies are inadequate to achieve a complete cure or durable long-term remission. The laboratories also concentrate upon the continued development of advanced drug creation and discovery technologies, an area in which our company's scientists already have a proven track record.
At the present time, we are concentrating our drug discovery research programs in the major therapeutic areas of cancer and diabetes. In the future, we intend to expand into additional therapeutic areas as well, including central nervous system disorders, autoimmune disorders, and infectious diseases.
In each therapeutic area in which Housey initiates a new drug discovery program, the company leverages its expertise in the field of cell-based assay technology by combining it with additional technologies in other areas to identify and create potential new drugs.
Our current research programs are focused upon specific forms of human cancer and both type 1 and type 2 diabetes. Collectively, these diseases represent major causes of chronic illness and mortality throughout the world today, especially in developed countries.